Attached files
| file | filename |
|---|---|
| 8-K - FORM 8-K - SALIX PHARMACEUTICALS LTD | d8k.htm |
| EX-99.1 - PRESS RELEASE - SALIX PHARMACEUTICALS LTD | dex991.htm |
Exhibit 16.1
March 9, 2011
Securities and Exchange Commission
100 F Street, N.E.
Washington, DC 20549
Commissioners:
We have read the statements made by Salix Pharmaceuticals, Ltd. (copy attached), which we understand will be filed with the Securities and Exchange Commission, pursuant to Item 4.01 of Form 8-K, as part of the Form 8-K of Salix Pharmaceuticals, Ltd. dated March 9, 2011. We agree with the statements concerning our Firm in such Form 8-K.
Very truly yours,
/s/ PricewaterhouseCoopers LLP